NCT05827939View on ClinicalTrials.gov

Association of Phenotypic Age and Antibody Titers Among SARS-Co-V2 Infected Patients and Vaccinated Groups

RecruitingOBSERVATIONAL

Enrollment

330

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

November 30, 2025

Conditions

COVID-19

Interventions

OTHER

Covid19 Vaccination dose

Participants above or below 2 dose Covid19 Vaccination

Trial Locations (1)

236

RECRUITING

TuCheng Hospital, New Taipei City

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER